A Phase 1 Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic Dermatitis
Condition: Atopic Dermatitis Interventions: Drug: KHK4323 IV/S; Drug: KHK4323 SC/S; Drug: KHK4323 IV/M; Drug: Placebo IV/S; Drug: Placebo IV/M; Drug: Placebo SC/S Sponsor: Kyowa Hakko Kirin Co., Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials